A939572 (A-939572) is is a novel, potent and orally bioavailable inhibitor of stearoyl-CoA desaturase1 (SCD1) with anticancer activity.

YTX 465 (YTX-465) is a stearoyl-CoA desaturase (SCD) inhibitor that strongly reduced fatty desaturation in a concentration-dependent manner.

Aramchol (Arachidyl amido cholanoic acid; C20-FABAC), a conjugate of cholic acid and arachidic acid, is a cholesterol solubilizer that prevents gallstone formation in inbred mice.

CAY10566 is a novel, orally bioavailable and selective SCD1 (stearoyl-CoA desaturase 1) inhibitor with IC50 values of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.

CVT-12012 (also known as CVT12012, CVT 12012) is an orally bioavailable stearoyl-coA desaturase (SCD) inhibitor (IC50s = 38 nM, 6.1 nM for rat microsomal and human HEPG2).

SCD1 inhibitor-3 is a potent SCD1 inhibitor.

SCD1 inhibitor-4 is a novel, potent, and orally bioactive stearoylCoA desaturase-1 (SCD1) inhibitor with a favorable pharmacokinetic profile to allow for sustained SCD inhibition in vivo.

GSK1940029 (also known as SCD Inhibitor 1) is a SCD Inhibitor that has the potential as a topical treatment for acne.